Sanofi (SNY) Common Equity (2009 - 2025)

Sanofi (SNY) has 14 years of Common Equity data on file, last reported at $83.1 billion in Q4 2025.

• Quarterly Common Equity changed 0.32% year-over-year to $83.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $83.1 billion (changed 0.32% YoY) and the FY2025 annual result came in at $83.1 billion, changed 0.32% from the prior year.
• Common Equity steadied at $83.1 billion in Q4 2025 per SNY's latest filing, from $82.8 billion in the prior quarter.
• The five-year high for Common Equity was $83.1 billion in Q4 2025, with the low at $76.3 billion in Q4 2022.
• Average Common Equity over 5 years is $80.1 billion, with a median of $79.7 billion recorded in 2023.
• Year-over-year, Common Equity grew 4.42% in 2021 and retreated 2.89% in 2022.
• Sanofi's Common Equity stood at $78.6 billion in 2021, then declined by 2.89% to $76.3 billion in 2022, then gained by 4.41% to $79.7 billion in 2023, then advanced by 3.97% to $82.8 billion in 2024, then advanced by 0.32% to $83.1 billion in 2025.
• Business Quant data shows SNY's Common Equity at $83.1 billion in Q4 2025, $82.8 billion in Q4 2024, and $79.7 billion in Q4 2023.